Compare ONL & TVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ONL | TVGN |
|---|---|---|
| Founded | 2021 | 2020 |
| Country | United States | United States |
| Employees | 40 | N/A |
| Industry | Real Estate Investment Trusts | Blank Checks |
| Sector | Real Estate | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 111.5M | 89.3M |
| IPO Year | N/A | N/A |
| Metric | ONL | TVGN |
|---|---|---|
| Price | $2.06 | $0.46 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | N/A | ★ $5.00 |
| AVG Volume (30 Days) | 284.6K | ★ 1.3M |
| Earning Date | 11-06-2025 | 11-14-2025 |
| Dividend Yield | ★ 3.96% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $149,775,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.46 | $0.38 |
| 52 Week High | $4.25 | $1.92 |
| Indicator | ONL | TVGN |
|---|---|---|
| Relative Strength Index (RSI) | 30.80 | 46.10 |
| Support Level | $1.92 | $0.40 |
| Resistance Level | $2.31 | $0.45 |
| Average True Range (ATR) | 0.10 | 0.04 |
| MACD | -0.02 | 0.01 |
| Stochastic Oscillator | 26.53 | 55.62 |
Orion Properties Inc is a internally-managed REIT engaged in the ownership, acquisition, and management of a diversified portfolio of mission-critical and headquarters office buildings located in high quality suburban markets across the U.S. and leased on a single-tenant net lease basis to creditworthy clients. The portfolio of the company includes traditional office buildings, governmental offices, medical offices, laboratories, and others. The Company operates in one business segment: direct ownership and operation of commercial real estate.
Tevogen Bio Holdings Inc a clinical-stage specialty immunotherapy company harnessing CD8+ cytotoxic T lymphocytes (CD8+ CTLs or CTLs), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders.